youth – Medxy AI

Varenicline Significantly Enhances Nicotine Vaping Cessation in Youth: Insights from a Landmark Randomized Clinical Trial

By MedXY 08/25/2025

A randomized clinical trial demonstrates that varenicline, combined with behavioral counseling, markedly improves nicotine vaping cessation rates in youth aged 16-25 who vape daily and do not regularly smoke tobacco.

Clinical Updates Wellness & Lifestyle

Adjunct-to-Insulin Therapy Using SGLT2 Inhibitors in Youth with Type 1 Diabetes: Clinical Impact and Renal Outcomes

By MedXY 08/21/2025

SGLT2 inhibitors adjunct to insulin improve glycemic control, reduce hyperfiltration, and are generally safe in youth with type 1 diabetes under careful ketone monitoring and DKA risk mitigation.

Wellness & Lifestyle

Teenage Brains on Trial: Navigating the Mental Health Minefield of Youth

By MedXY 07/25/2025

Exploring the unique challenges of adolescent brain development, this article unpacks the science, dispels myths, and offers practical strategies for supporting teen mental health.